Mission Bio is a biotechnology startup that operates in the field of cancer research. The company provides a unique technology platform, Tapestri, which allows researchers to analyze the genetic makeup of individual cells in a sample. This single-cell resolution can help identify rare genetic variations and provide a more detailed understanding of a patient's cancer.

The company's primary clients are cancer researchers and pharmaceutical companies developing cell and gene therapies. By providing a more detailed view of the genetic landscape of a tumor, Mission Bio's technology can help these companies develop more effective treatments and avoid late-stage failures in clinical trials.

Mission Bio operates in the rapidly growing market for genomics and precision medicine. The company's business model is based on selling its Tapestri platform and related services to researchers and pharmaceutical companies. The platform can measure multiple attributes within one assay, providing a comprehensive view of the genetic variations in a tumor. This can help researchers identify potential biomarkers that can be used to stratify patients, predict relapse, and signal resistance to treatment.

In summary, Mission Bio is a biotech startup that provides a unique technology platform for cancer research. The company's Tapestri platform allows researchers to analyze the genetic makeup of individual cells, providing a more detailed understanding of a patient's cancer and helping to develop more effective treatments.

Keywords: Biotechnology, Cancer Research, Single-Cell Genomics, Precision Medicine, Tapestri Platform, Genetic Variation, Biomarkers, Pharmaceutical Companies, Clinical Trials, Gene Therapy.